Disclosure Of First-Time Adoption [Text Block]

Ascelia Pharma - Filing #701899

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	405 827 SEK	678 831 SEK	—	307 834 SEK	—	307 834 SEK	– SEK	—	254,000 SEK	34 576 SEK	—	—	—	—	286 491 SEK	– SEK	493 731 SEK	236 056 SEK	28 697 SEK	—	119,000 SEK	—	—	236 056 SEK	—	—	—	237 062 SEK	– SEK	124,000 SEK	405 061 SEK	237 062 SEK	191 612 SEK	23 489 SEK
Comprehensive income	– SEK	—	—	125 768 SEK	—	135,000 SEK	—	—	– SEK	—	—	– SEK	125 768 SEK	125 903 SEK	98 702 SEK	—	—	—	—	—	98 697 SEK	—	– SEK	– SEK	—	5,000 SEK	– SEK	98 702 SEK	—	—	—	—	—	—	—
Profit (loss)	- SEK	—	—	125 903 SEK	—	- SEK	—	—	- SEK	—	—	- SEK	125 903 SEK	125 903 SEK	98 697 SEK	—	—	—	—	—	98 697 SEK	—	- SEK	- SEK	—	- SEK	- SEK	98 697 SEK	—	—	—	—	—	—	—